Patents Examined by Johann Richter
  • Patent number: 8158137
    Abstract: The present invention relates to nanomaterials comprised of metal oxides associated with cationic metals having antibacterial activity. In particular, the present invention relates to nanocrystalline compounds of formula (I): AOx-(L-Men+) i, (I) where AOx represents the metal oxide or metalloid oxide, with x=1 or 2; Me11“1” is a metal ion having antibacterial activity, with n=1 or 2; L is a bifunctional molecule, either organic or organometallic, capable of binding simultaneously with the metal oxide or metalloid oxide and the metal ion Men+; and i represents the number of L-Men+groups bound to a AOx nanoparticle.
    Type: Grant
    Filed: April 24, 2006
    Date of Patent: April 17, 2012
    Assignee: NM Tech Nanomaterials and Microdevices Technology Limited
    Inventors: Carlo Alberto Bignozzi, Valeria Dissette, Alfredo Corallini, Giacomo Carra′, Renato Della Valle
  • Patent number: 8153105
    Abstract: A sunblock or sunscreen composition with enhanced photostability and a method for preparing and using the novel photostabilizer are provided. The combination of avobenzene, dimethyl capramide, and polyester-8, a copolymer of adipic acid and neopentyl glycol that is terminated with cyanodiphenyl propenoic acid, provides an extra layer of protection to keep the sunscreen working longer to protect the skin from damaging ultraviolet rays, namely, UVA and UVB. Sunblock products with SPF-15 for moderate sun protection. SPF-30 for higher sun protection and SPF-50, specially formulated for fair skin provides high sun protection. The sunblock compositions with the novel photostabilizer have a clean, dry formula that glides on easily for quick absorption, while enlisting sea plant extracts and anti-oxidant vitamins A, C, and E that aid in the reduction of cell damaging free radicals for younger looking skin.
    Type: Grant
    Filed: July 1, 2008
    Date of Patent: April 10, 2012
    Assignee: Sun & Skin Care Research, Inc.
    Inventor: Gary DeAngelo
  • Patent number: 8153107
    Abstract: The instant invention relates to a process for the preparation of an aqueous suspension of anionic colloidal silica having a neutral pH which is stable over time and comprises individualized particles of colloidal silica which are not bound to one another by siloxane bonds. The instant suspensions show high storage stability and are particularly useful for the clarification of beer, for the preparation of cosmetic formulations, for the production of ink for printers, for paints and for anticorrosive treatments.
    Type: Grant
    Filed: January 26, 2011
    Date of Patent: April 10, 2012
    Assignee: AZ Electronic Materials USA Corp.
    Inventors: Eric Jacquinot, Marie-Laure Perard, Uwe Falk, Torsten Henning
  • Patent number: 8148355
    Abstract: 3-Hydroxy-7-hydroxy steroids and 3-oxo-7-hydroxy steroids, especially the 7?-isomers thereof, and pharmaceutically acceptable esters thereof are useful for protection against ischaemia-induced damage to peripheral organs, such as the heart or kidneys, as well as treatment of spiral cord injury.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: April 3, 2012
    Assignee: Hunter-Fleming Limited
    Inventor: Ernst Wulfert
  • Patent number: 8148393
    Abstract: A zolpidem tablet having modified release is designed as a tablet-in-tablet dosage form.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: April 3, 2012
    Assignee: Synthon BV
    Inventors: Frans van Dalen, Korinde Annemarie Jansen, Farid Abedin Dorkoosh
  • Patent number: 8147866
    Abstract: The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a subject a transmucosal drug delivery device comprising the medicament. Also provided are devices suitable for transmucosal administration of a medicament to a subject and methods of their administration and use. The devices include a medicament disposed in a mucoadhesive polymeric diffusion environment and a barrier environment.
    Type: Grant
    Filed: July 15, 2011
    Date of Patent: April 3, 2012
    Assignee: BioDelivery Sciences International, Inc.
    Inventors: Andrew Finn, Niraj Vasisht
  • Patent number: 8138122
    Abstract: A herbicidal composition which comprises 1-(2-chloroimidazo[1,2-a]pyridin-3-ylsulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea (imazosulfuron) and a compound represented by the formula (I): (Compound [I]) as active ingredients, wherein the weight ratio of imazosulfuron: Compound [I] is 1:0.1-1:10, has an excellent herbicidal activity for controlling weeds in crop fields or paddy fields, and causes no phytotoxicity against useful plants.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: March 20, 2012
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Hajime Ikeda, Satoru Kizawa
  • Patent number: 8138228
    Abstract: A liquid kelp formulation includes an enzyme inactivating component and a preservative to extend the shelf life of the formulation in terms of growth hormones. The formulation can also include a fertilizing additive, and a surfactant. A system is also provided whereby the kelp is maintained in solid form, and dissolved in water just prior to use. The solid form kelp and/or water can include additives, or additives in separate form, if used, can be added to either the kelp or the kelp solution.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: March 20, 2012
    Assignee: Accelegrow Technologies, Inc.
    Inventor: Louis B. Johnson
  • Patent number: 8138118
    Abstract: Compounds of the formula (I) or salts thereof in which R1 is carboxyl or a derivative of a carboxyl group, preferably a radical of the formula —CN, —C(?X)—Y—R or —C(?X)-Het, in which X is O, S or NRa or N—NRaRb, Y is O, S, NRc or NRc—NRdRe, R is H, a (subst.) hydrocarbon radical (HR) or acyl, and Het is an aliphatic nitrogen heterocycle, where each of the radicals Ra, Rb, Rc, Rd and Re is as defined for R or a radical of the formula —OR*, where R* is as defined for R, R2 is H or (subst.) HR or a heterocyclic radical, or, if Z?O or S, also an acyl radical, (R3)n are n radicals R3, as defined in claim 1, Z is a group of the formula O or S(O)x, where x=0, 1 or 2, and n is an integer 0, 1, 2, 3 or 4, as safeners for crop plants or useful plants against phytotoxic actions of agrochemicals, preferably as safeners against the action of pesticides, such as herbicides, in these plants.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: March 20, 2012
    Assignee: Bayer CropScience AG
    Inventors: Udo Bickers, Lothar Willms, Christopher Rosinger
  • Patent number: 8137659
    Abstract: A composition comprises a non-ionic surfactant and hydrophobic particles of metal oxide having the mean length of the primary particles in the range from 50 to 90 nm, the mean width of the primary particles in the range from 5 to 20 nm, and the median volume particle diameter of the secondary particles is less than 45 nm. The composition is particularly suitable for use in aqueous media, and can be used in a sunscreen product that exhibits both effective UV protection and improved transparency.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: March 20, 2012
    Assignee: Croda International PLC
    Inventor: Loma Margaret Kessell
  • Patent number: 8138226
    Abstract: Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, and/or premature ejaculation are described.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: March 20, 2012
    Assignee: Auspex Pharmaceuticals
    Inventors: Thomas G. Gant, Sepehr Sarshar
  • Patent number: 8137703
    Abstract: The present invention relates to an ozone water that has the potential to find useful applications in a wide variety of technical fields and is capable of maintaining the effects of wiping out microorganisms such as bacteria, viruses and the like and inhibiting the growth thereof over long periods. The present invention provides ozone nano-bubbles capable of staying in a solution for an extended period of time and a method for producing the ozone nano-bubbles by instantaneously shrinking the diameters of ozone microbubbles contained in an aqueous solution by the application of a physical irritation to the ozone microbubbles in an aqueous solution.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: March 20, 2012
    Assignees: REO Laboratory Co., Ltd., National Institute of AIST
    Inventors: Kaneo Chiba, Masayoshi Takahashi
  • Patent number: 8137704
    Abstract: A method of manufacturing digestible powder that generates a hydride ion (H?) when dissolved in water is provided. A vacuum oven system that can reach 600° C. and 10?5 torr is used within this method. The method according to this current application comprises of ten to eleven steps of vacuuming, heating and hydrogen treatment of coral reef powder. By adding mixtures of magnesium, phosphorus and potassium, the maximum treating temperature and vacuum pressure is lowered. The coral reef powders treated via the ten steps emit hydrogen when dissolved in the water like powders that are treated with a mixture of natural form of magnesium, phosphorus and potassium complex. Those natural form of the magnesium, phosphorous and potassium includes (NH4)MgPO4.6H2O (struvite), MgSO4.KCl.H2O (Kainite), K2SO4.MgSO4.6H2O (Schönite), K2SO4.MgSO4.4H2O (Leonite), and K2SO4.2MgSO4 (Langbeinite).
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: March 20, 2012
    Inventor: Tetsunori Kunimune
  • Patent number: 8136800
    Abstract: In order to provide a device and a method for increasing blood flow and an insulin-like growth factor with use of a large amount of carbonic gas nano bubbles, the device of the present invention includes: a bathtub 1; and a nano bubble-producing section 41 for producing carbonic gas nano bubbles in bath water in the bathtub 1.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: March 20, 2012
    Assignee: Sharp Kabushiki Kaisha
    Inventors: Kazuyuki Yamasaki, Takahide Miyamoto, Kazumi Chuhjoh, Masaki Kataoka
  • Patent number: 8133869
    Abstract: The present invention refers to biocidal mixtures with disinfecting and microbicidal activity which also enhance root growth, containing as active ingredients poly[beta(1,4)-2-amino-2-deoxyglucopyranose] oligomers as per formula I, and oxidized natural lignin phenols with a low molecular weight. It also refers to agronomically efficient compositions against fungi, bacteria, insects and nematodes which are harmful to plants in agricultural crops, as well as their uses in agriculture.
    Type: Grant
    Filed: March 5, 2008
    Date of Patent: March 13, 2012
    Inventor: Mary Lopretti
  • Patent number: 8133920
    Abstract: A growth hormone formulation includes an enzyme inactivating component and a preservative. The formulation can also include a fertilizing additive, and a surfactant. The growth hormone can be a natural one such as that found in kelp or a synthetic one or a combination of both.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: March 13, 2012
    Assignee: Accelegrow Technologies, Inc.
    Inventors: Louis B Johnson, Jeffery L Peel
  • Patent number: 8133848
    Abstract: A herbicidal composition comprising glyphosate in the form of a mixture of the potassium and ammonium salts.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: March 13, 2012
    Assignee: Nufarm Americas Inc.
    Inventors: Geoff Quick, Conrad Harwell, James Fickle
  • Patent number: 8133846
    Abstract: The present invention is directed to novel suspension concentrate compositions comprising finely milled crystalline sulfentrazone suspended in an aqueous glyphosate salt phase containing a surfactant component that chemically and physically stabilizes the composition.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: March 13, 2012
    Assignee: FMC Corporation
    Inventors: Frank J. Dominiani, Jr., Timothy Martin, Janie L. Zitomer
  • Patent number: 8133919
    Abstract: A growth hormone formulation includes an enzyme inactivating component and a preservative. The formulation can be incorporated into a dry fertilizer for application using the fertilizer itself or a component of the fertilizer such as one or more of the fillers commonly used in fertilizers.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: March 13, 2012
    Assignee: Accelegrow Technologies, Inc.
    Inventors: Louis B. Johnson, Jeffery L. Peel
  • Patent number: 8129312
    Abstract: The present invention relates to the use of specific amphiphilic alkoxyates as synergistic adjuvant for agrotechnical applications. Suitable agrotechnical compositions are also described. Thus, the addition of such alkoxylates makes possible an accelerated uptake of active ingredients by the plant. The alkoxylates to be used are alkoxylates based on branched alcohols such as 2-propylheptanol, C13-oxo alcohols and C10-oxo alcohols.
    Type: Grant
    Filed: April 24, 2003
    Date of Patent: March 6, 2012
    Assignee: BASF SE
    Inventors: Rainer Berghaus, Oskar Schmidt, Harald Köhle, Reinhard Stierl, Norbert Wagner, Paul Klingelhöfer